None listed
Conditions
Brief summary
This study will advance our understanding of the appropriate management of patients suffering AMI by quantifying the ability of controlled oxygen therapy to reduce adverse outcomes. Our findings will inform the development of guidelines for the local and international use of oxygen therapy in the treatment of AMI, with the potential to modify current practice. The findings of this study with directly benefit the Tasmanian community by improving health outcomes for AMI patients and reducing the overall burden of coronary heart disease in Tasmania.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
The study population will be patients attended by the Tasmanian Ambulance Service in the Launceston region with a complaint of non-traumatic chest pain and clinical features and history consistent with acute coronary syndrome and coronary heart disease (CHD). Cases will be considered for inclusion if they meet the following criteria: 1. Age over 18 years; and 2. Complaint of chest pain, pressure or tightness; and/or 3. Risk factor of acute coronary syndrome and CHD (include: hypertension, diabetes, dyslipodemia, age, sex, family history, smoking history and history of CHD); and/or 4. Ischaemic changes on electrocardiogram (ECG); and 5. Transported to the Launceston General Hospital by Tasmanian Ambulance Service. Eligible cases will be further defined by diagnosis of AMI, made by independent cardiologists, based on patient records (ECG and history), lab results (troponin, creatinine kinase (CK)) and/or evidence from coronary angiography.
Exclusion criteria
Cases will be excluded if no recordings of oxygen saturations are available.